Research Papers

25 of 2050 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Strategies for improving outcomes of COPD exacerbations.
Wilkinson T; Wedzicha JA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Biological targets for therapeutic interventions in COPD: clinical potential.
Pelaia G; Vatrella A; Gallelli L; Renda T; Caputi M; Maselli R; Marsico SA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Depression in COPD--management and quality of life considerations.
Stage KB; Middelboe T; Stage TB; Sørensen CH.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Cough and its importance in COPD.
Smith J; Woodcock A.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Cost-effectiveness of smoking cessation and the implications for COPD.
Faulkner MA; Lenz TL; Stading JA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Genotypes in matrix metalloproteinase 9 are a risk factor for COPD.
Tesfaigzi Y; Myers OB; Stidley CA; Schwalm K; Picchi M; Crowell RE; Gilliland FD; Belinsky SA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
A meta-analysis on the efficacy of oral theophylline in patients with stable COPD.
Molfino NA; Zhang P.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Use of Respimat Soft Mist inhaler in COPD patients.
Anderson P.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Newer fluoroquinolones in the treatment of acute exacerbations of COPD.
Patel A; Wilson R.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Salmeterol/fluticasone combination in the treatment of COPD.
Chung KF.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Changing the burden of COPD mortality.
Mannino DM; Kiriz VA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
The severity of airways obstruction as a determinant of treatment response in COPD.
Calverley P; Pauwels RA; Jones PW; Anderson JA; Vestbos J.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
The benefits of combined treatment with corticosteroids and long-acting beta agonists.
Singh D.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency.
Mayer AS; Stoller JK; Vedal S; Ruttenber AJ; Strand M; Sandhaus RA; Newman LS.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Comparison of oxygenation in peripheral muscle during submaximal aerobic exercise, in persons with COPD and healthy, ma…
Austin KG; Mengelkoch L; Hansen J; Shahady E; Sirithienthad P; Panton L.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled n…
Freiler JF; Arora R; Kelley TC; Hagan L; Allan PF.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Use of accelerometers to characterize physical activity patterns with COPD exacerbations.
Nguyen HQ; Steele B; Benditt JO.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study.
Faager G; Söderlund K; Sköld CM; Rundgren S; Tollbäck A; Jakobsson P.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessmen…
Pearson M; Ayres JG; Sarno M; Massey D; Price D.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Role of N-acetylcysteine in the management of COPD.
Sadowska AM; Verbraecken J; Darquennes K; De Backer WA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Immediate and early discharge for patients with exacerbations of chronic obstructive pulmonary disease: is there a role…
Chetty M; MacKenzie M; Douglas G; Currie GP.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
Hyperinflation and its management in COPD.
Puente-Maestu L; Stringer WW.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Respiratory disorders during sleep in chronic obstructive pulmonary disease.
Marrone O; Salvaggio A; Insalaco G.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
Is there any treatment other than drugs to alleviate dyspnea in COPD patients?
Ambrosino N; Vagheggini G.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations …
Cazzola M; Hanania NA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2006
2/6 Transparent
Funding Declared